Cortical atrophy and white matter density in the brains of schizophrenics and clinical response to neuroleptics

Acta Psychiatrica Scandinavica

Volumn 75, Issue 1, 1987, Pages 11-19

  Smith, R C ^a,b,c   Baumgartner, R ^a,b,c   Ravichandran, G K ^a,b,c   Largen, J ^a,b,c   Calderon, M ^a,b,c   Burd, A ^a,b,c   Mauldin, M ^a,b,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c Greater Houston Imaging   (United States)

Author keywords

brain density; brain morphology; cortical atrophy; schizophrenia

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; THIORIDAZINE;

BRAIN ATROPHY; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSIS; DRUG THERAPY; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOSIS; SCHIZOPHRENIA; THERAPY; WHITE MATTER;

ADULT; ANTIPSYCHOTIC AGENTS; ATROPHY; CEREBRAL CORTEX; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOPATHOLOGY; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; THIORIDAZINE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0023091748     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1987.tb02745.x     Document Type: Article

References (37)

1. Lateral cerebral ventricular enlargement in chronic schizophrenia
2. Structural abnormalities in cerebral cortex of chronic schizophrenia patients
3. Computed tomography in schizophreniform disorder and other acute psychiatric disorders
4. Cerebral ventricular size and cognitive impairment in chronic schizophrenia
5. Computed tomography in schizophrenics and normal volunteers: fluid volume
6. Normal ventricles in young schizophrenics
7. Abnormalities of brain structural density in schizophrenia
8. Schizophrenia and cerebral asymmetry detected by computed tomography
9. Computed tomography in schizophrenia
10. CT scans and schizophrenia: report on a workshop
11. Computed tomography of the brain in patients with acute psychosis and healthy volunteers
12. Ventricular enlargement in schizophrenia: definition and prevalence
13. Sulcal prominence in young chronic schizophrenic patients: CT scan findings associated with impairment on neuropsychological tests
14. Hemispheric asymmetries on computed tomographic scans in schizophrenics and manic: a controlled study and a critical review
15. Assymetriis in the densities of white and gray matter in the brains of schizophrenic patients
16. Central brain morphology in chronic schizophrenic patients: a controlled CT study
17. Cerebral ventricular enlargement in chronic schizophrenia: an association with poor response to treatment
18. Lateral ventricular size, psychopathology, and medication response in psychosis
19. Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms
20. Lateral ventricular enlargement and clinical response in schizophrenia
21. Neuropathology of schizophrenia
22. Research diagnostic criteria
23. RBC and plasma levels of haloperidol and clinical response in schizophrenia
24. Haloperidol: plasma levels and prolactin response as predictors of clinical improvement in schizophrenia; chemical vs radioreceptor plasma level assays
25. Plasma and red cell levels of thioridazine and clinical response in schizophrenia
26. Phenothiazine levels in plasma and red cells
27. Blood levels of neuroleptic drugs, clinical response, and plasma prolactin in chronic non‐responding schizophrenic patients.
28. Comparative efficacy of red cell and plasma haloperidol as predictors of clinical response in schizophrenia
29. Two syndromes of schizophrenia
30. Molecular pathology of schizophrenia: More than one disease process
31. Comparative studies of antipsychotic drugs in schizophrenia.
32. Negative symptoms in schizophrenia: definition and reliability
33. The quality of life scale: an instrument for rating schizophrenic negative symptoms
34. The development of scales for the assessment of negative and positive symptoms of schizophrenia